GLP-1 Agonists: Clinical Conundrums episode artwork

EPISODE · Apr 1, 2026 · 38 MIN

GLP-1 Agonists: Clinical Conundrums

from Medication Talk · host TRC Healthcare

Listen in as our expert panel tackles real-world questions about GLP-1 agonists, from starting them and setting expectations with patients to strategies for switching agents. You’ll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don’t respond to GLP-1 agonists.Special guests:Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, BCACP, CDCES, BC-ADMClinical Professor and Director of Pharmacy EducationUniversity of South Carolina College of PharmacyJennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADMProfessor and the Associate Dean for EducationUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesPanelists on TRC’s Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityFor the purposes of disclosure Dr. Jennifer Clements reports relevant financial relationships with Novo Nordisk (Ozempic, Rybelsus), Eli Lilly (Zepbound, tirzepatide) [speakers bureau].The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in February 2026. 🏷️ Use code mt1026 at checkout for 10% off. TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditClinical Resources:Comparison of GLP-1 and GIP/GLP-1 Receptor AgonistsGLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison ChartComparison of Weight Loss ProductsImproving Diabetes OutcomesDiabetes Medications: Cardiovascular and Kidney ImpactSend us Fan MailEmail us: [email protected] content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.Learn more about our product offerings at trchealthcare.com.

Episode metadata supplied by the publisher feed · Published Apr 1, 2026

Embed this episode

Listen in as our expert panel tackles real-world questions about GLP-1 agonists, from starting them and setting expectations with patients to strategies for switching agents. You’ll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don’t respond to GLP-1 agonists. Special guests: Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, BCACP, CDCES, BC-ADMClinical Professor and Director of Pharmacy EducationUniversity ...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

GLP-1 Agonists: Clinical Conundrums

0:00 38:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medication Talk?

This episode is 38 minutes long.

When was this Medication Talk episode published?

This episode was published on April 1, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Medication Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!